Online Exclusive

Literature Notes

A briefing of the latest findings in the literature, including:

• Ahlehoff O, Skov L, Gislason G, et al. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study [published online ahead of print September 11, 2012]. J Intern Med. doi:10.1111/j.1365-2796.2012.02593.x.
• Behrens F, Finkenwirth C, Pavelka K, et al. Leflunomide in psoriatic arthritis: results from a large European prospective observational study [published online ahead of print October 6, 2012]. Arthritis Care Res. doi:10.1002/acr.21848.
• Flaherty KT, Infante JR, Daud A, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations [published online ahead of print September 29, 2012]. N Engl J Med. 2012;367:1694-1703.
• Uchiyama M, Egusa C, Hobo A, et al. Multivariate analysis of prognostic factors in patients with rapidly progressive alopecia areata [published online ahead of print September 24, 2012]. J Am Acad Dermatol. doi:10.1016/j.jaad.2012.06.006.
• Kubica AW, Brewer JD. Melanoma in immunosuppressed patients. Mayo Clin Proc. 2012;87:991-1003.

Share: